← Leaderboards
Philip J. Proteau
Oregon State University
$1,159,995
Attributed
$1,159,995
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $219.3K · FY2010–11$250K$187.5K$125K$62.5K$0
'10
'11
Funding mix
By agency
NIH$1,159,995 · 2
By mechanism
R01$759,772 · 1
R21$400,223 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon State University
Same institution · by research overlap
- Taifo Mahmud$4,578,703
- William H Gerwick$18,766,860
- Zhengrong Cui$6,259,250
- Kerry Leigh McPhail$1,864,185
- Richard B Van Breemen$16,123,650
Others in their field
Top investigators on “Enzymes”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$83,824,814
- Stuart L Schreiber · Harvard University (Medical School)$49,424,554
- Jay D Keasling · University Of California-Berkeley$47,558,861
- David Heimbrook · Leidos Biomedical Research, Inc.$47,513,682
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
EnzymesIsoprenoidEnzyme SubstrateRecombinant ProteinsAntibacterial AgentsEnzyme InhibitorsMevalonateIsomerasePhotosynthetic BacteriaProtein PurificationMolecular CloningBiosynthesisSite Directed MutagenesisEnzyme MechanismHelicobacterDrug Design /Synthesis /ProductionDideoxy Chain Termination Dna SequencingCytochromesBacterial InfectionsCytochrome P450FamilyComplexAreaEscherichia Coli
Grant awards (6)
Pleuromutilin Biosynthetic Studies$180,923
R21 · FY2011 · AI · contact PI
Pleuromutilin Biosynthetic Studies$219,300
R21 · FY2010 · AI · contact PI
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES$193,888
R01 · FY2003 · AI
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES$188,241
R01 · FY2002 · AI
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES$182,758
R01 · FY2001 · AI
ISOPRENOID BIOSYNTHESIS: NON-MEVALONATE PATHWAY STUDIES$194,885
R01 · FY2000 · AI